ArriVent BioPharma's furmonertinib demonstrates robust efficacy, CNS penetration, and tolerability in early trials. Read why ...

MSTR stock price has dropped nearly 66% over the past six months, falling from above $450 to the $150 region, a decline that ...

The open looks are maddening, but the tradeoffs behind them are clear. Whether they hold up in SEC play is another matter.

The U.S. used to have a stockpile, but such ideas were considered quaint after the end of the Cold War and the ascent of neoliberalism. We could have positioned the nation to weather this storm, but ...

Discover key insights for investors navigating the complex equity landscape of 2026, influenced by liquidity, fundamentals, ...

Dhurandhar is dominating the Indian box office, with earnings on the verge of Rs 782.2 crore, setting it on track to become ...

How Nutrition Advice Has Changed From the 1950s to Today I knew I wasn’t imagining it. Years ago, the topic of the Seven ...

This guide values Venezuela’s oil in layers: the in-ground headline math, the heavy-crude reality check, and the monetizable ...

The stock market’s odds of rising in 2026 are the same — regardless of how it performs at the beginning. It’s unclear when ...

LeBron James' longtime agent and friend Rich Paul had some controversial takes during his interview with Max Kellerman on the ...

This small-cap industrial is quietly working through a transition. A tighter operating posture, a richer product mix and ...